I am a rheumatologist working at UTHealth in Houston, Texas.
Joined April 2019
- Tweets 37
- Following 20
- Followers 248
- Likes 21
8 Photos and videos
27 Oct 2024
Ryan’s first ever 10k run! UTHealth Houston 10k today. Wonderful weather and so much positive energy.
3
230
Assassi retweeted
30 Jul 2024
Dr. Assassi attended the CONQUER Investigators Capillaroscopy Workshop in Nashville. Many thanks to Dr. Tracy Frech for organizing this event. #scleroderma
1
4
582
Assassi retweeted
20 Nov 2022
Dr. Yvette Farran (2nd year fellow) challenging the rheumatology crowd with an unusual case of Takayasu's disease at the Thieves Market session during the ACR Convergence Meeting 2022.
1
5
Assassi retweeted
20 Nov 2022
Proud of Nancy Wareing (MD/PhD candidate) who gave a wonderful presentation on long-term blood gene expression changes in scleroderma patients undergoing myeloablation followed by autologous stem cell transplantation at the ACR Convergence Meeting 2022
1
2
2
Assassi retweeted
16 Sep 2022
Longitudinal global transcriptomic profiling of preclinical scleroderma pubmed.ncbi.nlm.nih.gov/3604…
Congrats to Drs. Bellocchi, Beretta, and Assassi on publishing the first global gene expression profiling study of preclinical systemic sclerosis
#scleroderma
#UTHealth
2
2
Assassi retweeted
27 Jun 2022
Congratulations to the 2022 Rheumatology Fellowship Class!
1
2
Assassi retweeted
28 Jun 2022
Congrats to Drs. Skaug and Lam on publishing the largest case series on individuals with false positive Scl-70 results - This real life experience underscores the importance of accurate antibody testing in rheumatology. pubmed.ncbi.nlm.nih.gov/3575…
1
3
Assassi retweeted
29 Jun 2022
Congrats to Nancy Wareing for defending her PhD thesis on the role of SIX-1 in systemic sclerosis on World Scleroderma Day
#scleroderma
1
4
Assassi retweeted
23 Feb 2022
Peripheral blood gene expression profiling can help identify systemic sclerosis-ILD patients who are likely responders to mycophenolate - Dr. Assassi and colleagues' recently published manuscript in ARD:
ard.bmj.com/content/early/20…
1
2
1
Assassi retweeted
2 Nov 2021
Drs. Wu and Assassi's review article on type I interferon pathway as a potential therapeutic target in systemic sclerosis:
#scleroderma #systemic sclerosis #interferon
rdcu.be/czPvb
1
1
Assassi retweeted
1 Nov 2021
Congratulations to Dr. Mark Hwang for receiving Spondylitis Association of America/Bruckel Early Career Investigator Award.
med.uth.edu/blog/2021/10/25/…
3
2
21
Assassi retweeted
17 Oct 2021
Congrats to Dr. John Reveille for receiving the Anibal Ruiz Moreno Award from Pan American League of Associations for Rheumatology.
1
6
Assassi retweeted
2 Jul 2021
Our immense gratitude to Dr. Jammie Barnes for her service as UTHealth Rheumatology Program Director (2016-21). Excited to welcome Dr. Courtney McCray as our next Program Director. She will take our fellowship program to new heights.
1
7
Assassi retweeted
2 Jul 2021
@UTHealthRheum would like to welcome Yvette Farran, Amy Le, and Karim Doughem to our fellowship program. We are excited to have matched such a talented group of fellows! @McGovernMed @UTHealthHouston
1
2
Assassi retweeted
22 Jun 2021
Congratulations to our graduating @UTHealthRheum fellows! We are so proud of you! Best wishes for your next adventure. @McGovernMed @UTHealth
1
4
Assassi retweeted
15 Dec 2020
Our study on characterization of systemic sclerosis serum protein profile and cross-comparison to peripheral blood cell transcriptome: Differential expression for most serum proteins in SSc is likely to originate outside the peripheral blood cells.
pubmed.ncbi.nlm.nih.gov/3313…
2
Assassi retweeted
13 Dec 2020
Despite these unusual times, our Division knows how to have fun together. #Holiday Party
2
2
9
Assassi retweeted
27 Oct 2020
Congratulations to @patti_katz!
27 Oct 2020
Congratulations to Patricia Katz, PhD, recipient of the 2020 Master Designation! @UCSFRheum #ACR20
2
11
Assassi retweeted
25 Oct 2020
Congrats to Dr. Maureen Mayes for receiving the UTHealth President's Research Scholar Award for her important contribution to understanding the molecular and clinical aspects of systemic sclerosis (scleroderma).
bit.ly/35rUWw8
#scleroderma
1
2
5